Rob Vanalst

Q: What is Rob Van Alst email address?

Email Rob Van Alst at rahvanalst@gmail.com and rob.vanalst@synthon.com. This email is the most updated Rob Van Alst's email found in 2026.

Q: How to contact Rob Van Alst?

To contact Rob Van Alst send an email to rahvanalst@gmail.com or rob.vanalst@synthon.com. (updated on March 07, 2025)

Director USA & Canada at Synthon | Arnhem-Nijmegen Region

About Rob Vanalst

Rob Van Alst currently serves as the Director for the USA & Canada at Synthon, where he plays a pivotal role in expanding the company's footprint across North America. With a strategic, commercial mindset and a curious, positive outlook, Rob leverages his extensive experience in senior and strategic business development to identify and capitalize on new partnership opportunities. His expertise in licensing out ANDA and 505(b)(2) products in the U.S., along with managing Synthon’s specialty and generic pipeline in Canada, positions him as a key driver of growth in the region. Rob’s approach combines a deep understanding of the pharmaceutical landscape with a consultative style, enabling him to build strong, mutually beneficial relationships with partners and stakeholders.

At Synthon, Rob is actively involved in growing the partner network and portfolio, ensuring alignment with the company’s strategic objectives and regulatory requirements. His leadership has contributed to the realization of extensive growth, with 100% of portfolio developments for 2030 either partnered or in the final phases of development. His skills in strategic negotiations, business strategy, and relationship building are instrumental in navigating complex licensing deals and product management challenges. Rob’s high level of industry insight, combined with his analytical thinking and management expertise, allows him to develop innovative solutions that meet market demands. His positive, enthusiastic demeanor and sense of humor foster a collaborative environment, making him a trusted partner in the pharmaceutical industry. Overall, Rob Van Alst’s strategic vision and commercial acumen continue to position Synthon as a formidable player in the North American generics and specialty pharmaceutical markets.

Rob Vanalst Work